Effective at the opening of trading on the Effective Date, the Company’s pre-consolidated common shares will be delisted from the Exchange and the post-consolidated common shares will commence trading ...

Connor Clark & Lunn Investment Management Ltd. cut its holdings in shares of Commercial Metals (NYSE:CMC – Free Report) by 77 ...

China Yuchai International Limited ("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery ...

Vantage Markets is honored to announce its recognition at the World Business Outlook Awards 2025, receiving accolades for ...

China International Development Corporation Limited ("CIDC" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 0264) is pleased to announce the successful establishment of its ...

There’s already been a record rotation out of the US and into European equities, according to Bank of America’s fund manager ...

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

Also, they need to fulfil the criteria of having competitions for women, girls, and boys to access the full funding.” ...

Victory Capital Management Inc. boosted its holdings in shares of Koppers Holdings Inc. (NYSE:KOP – Free Report) by 9.3% during the 4th quarter, according to its most recent disclosure with the ...

Abeona Therapeutics Inc (ABEO) reports strong cash reserves and anticipates FDA approval for its promising treatment, pz-cel, ...

Despite the proliferation of technology in warfare, military strength cannot solely be measured by technological capability.

Bi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat blood cancers such as leukemia, lymphoma, and multiple myeloma.